SCHEMBL4798170

SCHEMBL4798170

CC(C)(C)OC(=O)NC(CC1CCCCC1)C(=O)N[C@@H](CC(=O)OCc1ccccc1)CN1CCc2cc(F)ccc21

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CTSS P25774 20/20 0.68
CTSL P07711 13/20 0.57
CTSK P43235 6/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4798183 1.00 CTSS (0.68) CTSSCTSLCTSK
SCHEMBL4798175 1.00 CTSS (0.68) CTSSCTSLCTSK
SCHEMBL4800025 0.94 CTSS (0.69) CTSSCTSLCTSK
SCHEMBL4800028 0.94 CTSS (0.69) CTSSCTSLCTSK
SCHEMBL4800107 0.90 CTSS (0.68) CTSSCTSLCTSK
SCHEMBL4800098 0.90 CTSS (0.68) CTSSCTSLCTSK
SCHEMBL4796954 0.85 CTSS (0.89) CTSSCTSLCTSK
SCHEMBL4796948 0.85 CTSS (0.89) CTSSCTSLCTSK
SCHEMBL4799969 0.84 CTSS (0.59) CTSSCTSLCTSK
SCHEMBL4799962 0.84 CTSS (0.59) CTSSCTSLCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242671-A1 INHIBITORS OF CATHEPSIN S IRM LLC (BM) 2008-10-02 US claimed
US-20080242671-A1 INHIBITORS OF CATHEPSIN S IRM LLC (BM) 2008-10-02 US disclosed
US-7384970-B2 Inhibitors of cathepsin S IRM LLC (BM) 2008-06-10 US disclosed
US-20040248887-A1 Inhibitors of cathepsin S IRM LLC (BM) 2004-12-09 US disclosed
WO-2004084843-A2 INHIBITORS OF CATHEPSIN S IRM LLC (BM) 2004-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248887-A1 Inhibitors of cathepsin S CTSS, CTSB, CTSZ CTSS 1/4885CTSL 11/4885CTSK 9/4885
US-20080242671-A1 INHIBITORS OF CATHEPSIN S CTSS, CTSB, CTSZ CTSS 1/4885CTSL 11/4885CTSK 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.